Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
US-2015368676-A1 · Dec 24, 2015 · US
US11946092B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11946092-B2 |
| Application number | US-202218051024-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2022 |
| Priority date | Apr 8, 2022 |
| Publication date | Apr 2, 2024 |
| Grant date | Apr 2, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing 2-keto-3-deoxygluconate (KDG) from 2-(acetylamino)-2-deoxy-D-gluconic acid (GlcNAc1A) by two enzymes; GlcNAc1A is converted to KDG by incubating GlcNAc1A with a deacetylase OngB at 25° C. for 4-12 h and then with a deaminase OngC at 25° C. for another 10-15 h; it constructs two engineered E. coli/pET22b-ongB (carrying the ongB gene) and E. coli/pET22b-ongC (carrying the ongC gene) strains to prepare recombinant proteins OngB and OngC, respectively; at the action of these two enzymes, OngB and OngC, GlcNAc1A is converted to KDG, which solves the bottleneck of GlcNAc1A utilization during the bioconversion of chitin; the KDG is an important metabolic intermediate to synthesize furan derivatives, herbicides, food additives and other industrially important chemical compounds, having wide industrial applications.
Opening claim text (preview).
What is claimed is: 1. A method for producing 2-keto-3-deoxygluconate (KDG) from 2-(acetylamino)-2-deoxy-D-gluconic acid (GlcNAc1A), wherein said method comprises contacting GlcNAc1A with a deacetylase having the amino acid sequence of SEQ ID NO: 3 and a deaminase having the amino acid sequence of SEQ ID NO: 4 for 1-24 h to generate KDG. 2. The method according to claim 1 , wherein the method for producing KDG is carried out by the successive addition of the deacetylase and the deaminase, wherein GlcNAc1A is first incubated with the deacetylase at 25° C. for 12 h, and then with the deaminase at 25° C. for another 12 h. 3. The method according to claim 1 , wherein the molar ratio of the deacetylase to GlcNAc1A is 1:900-1:1100. 4. The method according to claim 1 , wherein the molar ratio of the deaminase to the deacetylase is 1:9-1:11. 5. The method according to claim 1 , wherein the deacetylase is encoded by a deacetylase DNA having the nucleotide sequence of SEQ ID NO: 1. 6. The method according to claim 1 , wherein the deaminase is encoded by a deaminase DNA having the nucleotide sequence of SEQ ID NO: 2.
Hydroxy-carboxylic acids · CPC title
acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
in linear amides (3.5.1) · CPC title
in cyclic amidines (3.5.4) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.